Alto Neuroscience, Inc. Net Cash Provided by (Used in) Financing Activities in USD from Q1 2023 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Alto Neuroscience, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2023 to Q1 2025.
  • Alto Neuroscience, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $9.13M, a 93.2% decline year-over-year.
  • Alto Neuroscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $136M, a 99.2% increase from 2023.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Alto Neuroscience, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $9.13M -$125M -93.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 $135M +$110M +438% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 $25M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14

Alto Neuroscience, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $136M +$67.6M +99.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $68.1M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.